Erin L. Schenk

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

Ashley Maynard, Caroline E. McCoach, Julia Rotow et al. · Cell · 2020 · 666 citations · Full text

Cancer Cell–Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti–PD-1 Therapy in Lung Adenocarcinoma

Amber M. Johnson, Bonnie Bullock, Alexander Neuwelt et al. · The Journal of Immunology · 2020 · 127 citations · Full text

Lung Adenocarcinoma, Immunology, Immunologic Mechanism +18

LBA61 First analysis of RAIN-701: Study of tarloxotinib in patients with non-small cell lung cancer (NSCLC) EGFR Exon 20 insertion, HER2-activating mutations & other solid tumours with NRG1/ERBB gene fusions

Stephen V. Liu, Liza C. Villaruz, Victor Lee et al. · Annals of Oncology · 2020 · 79 citations

A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study

Erin L. Schenk, Sumithra J. Mandrekar, Grace K. Dy et al. · Journal of Thoracic Oncology · 2019 · 60 citations · Full text

Es Sclc, Oncology, Vaccine Trial +8

Effects of Selective Checkpoint Kinase 1 Inhibition on Cytarabine Cytotoxicity in Acute Myelogenous Leukemia Cells <i>In Vitro</i>

Erin L. Schenk, Brian D. Koh, Karen S. Flatten et al. · Clinical Cancer Research · 2012 · 54 citations · Full text